StockNews.com upgraded shares of Amgen (NASDAQ:AMGN – Get Rating) from a buy rating to a strong-buy rating in a research note issued to investors on Thursday. AMGN has been the topic of several other reports. Piper Sandler decreased their price objective on shares of Amgen from $293.00 to $288.00 in a report on Friday, April […]
Weaver C. Barksdale & Associates Inc. cut its stake in Amgen Inc. (NASDAQ:AMGN – Get Rating) by 11.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,611 shares of the medical research company’s stock after selling 1,086 shares during the quarter. Amgen […]
Grey Fox Wealth Advisors LLC bought a new stake in Amgen Inc. (NASDAQ:AMGN – Get Rating) in the fourth quarter, HoldingsChannel.com reports. The firm bought 463 shares of the medical research company’s stock, valued at approximately $122,000. A number of other hedge funds and other institutional investors also recently bought and sold shares of AMGN. […]
Campbell & CO Investment Adviser LLC purchased a new position in shares of Amgen Inc. (NASDAQ:AMGN – Get Rating) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 7,689 shares of the medical research company’s stock, valued at approximately $2,019,000. Amgen […]
Pathstone Family Office LLC increased its stake in Amgen Inc. (NASDAQ:AMGN – Get Rating) by 9.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,005 shares of the medical research company’s stock after acquiring an additional 1,904 shares during the […]